Longitudinal study of serum carotenoid, retinol, and tocopherol concentrations in relation to breast cancer risk among postmenopausal women.

BACKGROUND Prospective studies have examined the association of serum and plasma carotenoids and micronutrients and breast cancer; however, to date, studies have only assessed exposure at one point in time. OBJECTIVE This study analyzed baseline and repeated serum measurements of carotenoids, retinol, and tocopherols to assess their associations with postmenopausal breast cancer risk. DESIGN Serum concentrations of alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, lutein + zeaxanthin, retinol, alpha-tocopherol, and gamma-tocopherol were measured in a 6% sample of women in the Women's Health Initiative clinical trials at baseline and at years 1, 3, and 6 and in a 1% sample of women in the observational study at baseline and at year 3. The association of baseline compounds and breast cancer risk was estimated by Cox proportional hazards models. In addition, repeated measurements were analyzed as time-dependent covariates. Of 5450 women with baseline measurements, 190 incident cases of breast cancer were ascertained over a median of 8.0 y of follow-up. RESULTS After multivariable adjustment, risk of invasive breast cancer was inversely associated with baseline serum alpha-carotene concentrations (hazard ratio for highest compared with the lowest tertile: 0.55; 95% CI: 0.34, 0.90; P = 0.02) and positively associated with baseline lycopene (hazard ratio: 1.47; 95% CI: 0.98, 2.22; P = 0.06). Analysis of repeated measurements indicated that alpha-carotene and beta-carotene were inversely associated with breast cancer and that gamma-tocopherol was associated with increased risk. CONCLUSIONS The present study, which was the first to assess repeated measurements of serum carotenoids and micronutrients in relation to breast cancer, adds to the evidence of an inverse association of specific carotenoids with breast cancer. The positive associations observed for lycopene and gamma-tocopherol require confirmation. This trial was registered at ClinicalTrials.gov as NCT00000611.

[1]  K. Moysich,et al.  Diet and breast cancer , 2007, Cancer.

[2]  E. Riboli,et al.  The second expert report, Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective , 2007 .

[3]  Zhao Chen,et al.  Ethnicity and breast cancer: factors influencing differences in incidence and outcome. , 2005, Journal of the National Cancer Institute.

[4]  J. Buring,et al.  Dietary and Plasma Lycopene and the Risk of Breast Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[5]  W. Willett,et al.  Plasma carotenoids, retinol, and tocopherols and risk of breast cancer. , 2005, American journal of epidemiology.

[6]  A. Tari,et al.  How retinoids regulate breast cancer cell proliferation and apoptosis , 2004, Cellular and Molecular Life Sciences CMLS.

[7]  E. Riboli,et al.  Carotenoids, alpha-tocopherols, and retinol in plasma and breast cancer risk in northern Sweden , 2004, Cancer Causes & Control.

[8]  C. Swanson,et al.  Relationships of serum carotenoids, retinol, α-tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States) , 2004, Cancer Causes & Control.

[9]  A. Nahum,et al.  Modulation of transcriptional activity by antioxidant carotenoids. , 2003, Molecular aspects of medicine.

[10]  A. Alberg,et al.  Prospective study of carotenoids, tocopherols, and retinoid concentrations and the risk of breast cancer. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  E Riboli,et al.  Serum carotenoids and breast cancer. , 2001, American journal of epidemiology.

[12]  T. Rohan.  Invited commentary: serum carotenoids and breast cancer. , 2001, American journal of epidemiology.

[13]  M. Gross,et al.  The repeatability of serum carotenoid, retinoid, and tocopherol concentrations in specimens of blood collected 15 years apart. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14]  JoAnn E. Manson,et al.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.

[15]  R. Mehta,et al.  Retinoids as chemopreventive agents for breast cancer. , 1992, Cancer detection and prevention.

[16]  L. Kaplan,et al.  Simultaneous measurement of serum retinol, tocopherols, carotenes, and carotenoids by high performance liquid chromatography , 1987 .

[17]  K. Miller,et al.  Simultaneous determination of plasma retinol, α-tocopherol, lycopene, α-carotene, and β-carotene by high-performance liquid chromatography , 1984 .

[18]  M H Gail,et al.  Evaluating serial cancer marker studies in patients at risk of recurrent disease. , 1981, Biometrics.